Wockhardt shares came under pressure in Friday’s session, falling over 3% after the company posted disappointing Q1 FY26 results. As of 2:24 PM, the shares were trading 2.85% lower at Rs 1,478.40.
The pharma firm reported a net loss of ₹90 crore, significantly higher than the loss of ₹14 crore recorded in the same period last year. Revenue for the quarter stood flat at ₹739 crore on a year-on-year basis.
Operational performance also weakened, with EBITDA declining 20.9% to ₹72 crore compared to ₹91 crore in Q1 FY25. The company’s operating margin slipped to 9.8% from 12.3% a year ago, reflecting rising costs and pressures on profitability.
On the stock market, Wockhardt opened the day at ₹1,530.10 and touched an intraday high of ₹1,548.80 before slipping to a low of ₹1,448. Over the past 52 weeks, the scrip has traded between ₹854 and ₹1,868.80.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.